A Mini Review : Clinically Significant Potential Drug-Drug Interactions In COVID-19 and Comorbid Therapy

A Mini Review : Clinically Significant Potential Drug-Drug Interactions In COVID-19 and Comorbid Therapy

Coronavirus disease 2019 (COVID-19) is a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and can be aggravated by comorbid diseases. In administering COVID-19 therapy, we need to consider potential drug-drug interactions (pDDIs) with comorbid drugs. Most patients with...

Full description

Bibliographic Details
Main Authors: Ana Khusnul Faizah, Nani Wijayanti Dyah Nurrahman, Oki Nugraha Putra
Format: Article
Language:English
Published: Universitas Indonesia 2020-07-01
Series:Pharmaceutical Sciences and Research
Subjects:
covid-19
hydroxychloroquine
remdesivir
azithromycin
pddis
lopinavir
Online Access:https://scholarhub.ui.ac.id/psr/vol7/iss4/3/

Internet

https://scholarhub.ui.ac.id/psr/vol7/iss4/3/

Similar Items